SABRIL (vigabatrin) is a prescription medicine used with other therapies in grownups and children 2 years old and older with refractory facility partial seizures (CPS) that have actually not reacted well enough to several other treatments and if the feasible advantages surpass the risk of vision loss.
It is advised that your healthcare provider test your (or your child's) vision before or within 4 weeks after beginning SABRIL and at least every 3 months throughout therapy up until SABRIL is stopped. Tell your doctor if you or your youngster have any type of adverse effects that bothers you or that does not vanish.
Tell your healthcare provider immediately if seizures get worse. If you must take SABRIL while you are expecting, you and your health care carrier will certainly have to make a decision. One of the most common adverse effects of SABRIL in adults include: obscured vision, sleepiness, lightheadedness, troubles strolling or feeling unskillful, shaking (tremor), and exhaustion.